From silencing rogue genes to enhancing immune responses...

From silencing rogue genes to enhancing immune responses, oligonucleotides are revolutionizing precision medicine.Antisense oligos, siRNAs, miRNAs, aptamers, and DNAzymes are not just tools—they're next-gen therapies with the power to treat cancer, rare genetic disorders, and beyond.At SmaBio Labs, we’re tracking these innovations closely, especially as delivery systems and AI-driven design tools unlock new therapeutic possibilities. With the global oligo market projected to quadruple by 2034, the future is coded in nucleotides.References: http://bit.ly/4jWU2fH